Evidence map›Paper›PMID 23872745›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2013

Racial differences in the incidence and clearance of human papilloma virus (HPV): the HPV in men (HIM) study.

Matthew B Schabath, Luisa L Villa, Hui-Yi Lin, William J Fulp, Gabriel O Akogbe, Martha E Abrahamsen, Mary R Papenfuss, Eduardo Lazcano-Ponce, Jorge Salmerón, Manuel Quiterio and 1 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Matthew B SchabathAuthors' Affiliations: Department of Cancer Epidemiology and Center for Infection Research in Cancer (CIRC); Department of Biostatistics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Ludwig Institute for Cancer Research, Sao Paulo, Brazil; Instituto Nacional de Salud Pública; and Instituto Mexicano del Segurio Social, Cuernavaca, Mexico.
Luisa L Villa
Hui-Yi Lin
William J Fulp
Gabriel O Akogbe
Martha E Abrahamsen
Mary R Papenfuss
Eduardo Lazcano-Ponce
Jorge Salmerón
Manuel Quiterio
Anna R Giuliano
Instituto Paulo Gontijo · BRInstituto Nacional de Salud Pública · MXMexican Social Security Institute · MXMoffitt Cancer Center · US

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
Natural History of HPV Infection in Men: The HIM StudyR01CA098803 · NCI · H. LEE MOFFITT CANCER CTR &RES INST · PI GIULIANO, ANNA R. · 2004 to 2014
$18.2M
NCI NIH HHS P30 CA076292NCI NIH HHS R01 CA098803NCI NIH HHS R01CA098803
6 · The paper itself

Abstract

backgroundThis analysis assessed the acquisition (incidence) and persistence (clearance) of human papilloma virus (HPV) infection by self-reported race among men in The HPV in Men (HIM) Study, a multinational prospective study of the natural history of genital HPV infections.

methodsSelf-reported race was categorized as White, Black, Asian/Pacific Islander (PI), or multiple and mixed race. Genital samples were combined for HPV DNA testing and categorized by any, oncogenic, and non-oncogenic HPV infections.

resultsAsian/PI race had significantly the lowest incidence of any, oncogenic, and non-oncogenic HPV infection (P < 0.001). In multivariable analyses, Asian/PI race was associated with a lower probability of acquiring any [HR = 0.63; 95% confidence interval (CI), 0.42-0.95] and non-oncogenic HPV infection (HR = 0.61; 95% CI, 0.40-0.93) when compared to Whites. No significant associations were evident for Asian/PI race for clearance. Multiple and mixed race was significantly associated with lower probability of acquiring non-oncogenic HPV infection (HR = 0.83; 95% CI, 0.69-0.99) and borderline significant associations were observed for any HPV (HR = 0.91) and oncogenic infections (HR = 0.92). Multiple and mixed race was associated with a lower probability of clearing any (HR = 0.92; 95% CI, 0.84-1.00) and oncogenic HPV infections (HR = 0.85; 95% CI, 0.75-0.95).

conclusionAsian/PI race had the lowest incidence of HPV and exhibited a lower probability of acquiring new HPV infections. Multiple and mixed race had the second lowest incidence of infection and was associated with a lower probability of acquiring and clearing an HPV infection. IMPACT: Race-specific differences in HPV infection could be due to behavior, innate genetic differences, or circulating intratypic HPV variants.

Indexed as

AdolescentAdultAgedBrazilFloridaGenital Diseases, MaleGenotypeHumansIncidenceMaleMexicoMiddle AgedPapillomaviridaePapillomavirus InfectionsProspective StudiesRisk Factors

Identifiers

PMID23872745
PMCPMC3795913
OpenAlexW2072247985

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.